Maverix Medical Advances Lung Cancer Diagnosis With Narwhal
Menlo Park, California, August 20, 2026 Maverix Medical has announced that the U.S. Food and Drug Administration (FDA) granted...
lung cancer
Advertisement
BioNTech Advances Lung Cancer Pipeline Ahead of WCLC 2026
MAINZ, Germany, August 20, 2026 BioNTech SE is set to highlight major progress across its lung cancer clinical development...
Leads Biolabs Advances LBL-024 Data in First-Line NSCLC
NANJING, China, August 20, 2026 Leads Biolabs announced that the full abstract for its Phase II study of LBL-024...
Johnson & Johnson Advances MONARCH QUEST 3 Bronchoscopy
Santa Clara, California, August 17, 2026 Johnson & Johnson announced U.S. 510(k) regulatory clearance for MONARCH™ QUEST 3, the...
BlossomHill Therapeutics Gains FDA Fast Track for BH-30643
San Diego, California, August 18, 2026 BlossomHill Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has...
Advertisements
AstraZeneca Discontinues eVOLVE-Lung02 Phase 3 Trial
Cambridge, UK — August 17, 2026 AstraZeneca announced that it is discontinuing the eVOLVE-Lung02 Phase III trial evaluating volrustomig...
Henlius and Sandoz Expand Global Strategic Biosimilar Effort
Shanghai, China, August 17, 2026 Shanghai Henlius Biotech, Inc. and Sandoz have entered into a strategic collaboration to expand...
Daiichi Sankyo and AstraZeneca Report Enhertu Phase 3 Win
Tokyo, Japan — August 17, 2026 Daiichi Sankyo and AstraZeneca announced positive topline results from the DESTINY-Lung04 Phase 3...
AbelZeta Regains C-CAR039 Rights After FDA IND Clearance
Rockville, Maryland and Shanghai, China, August 17, 2026 AbelZeta Pharma, Inc. announced that the U.S. Food and Drug Administration...
Lantheus Wins FDA Approval for Tau PET Agent in Alzheimer’s
Bedford, Massachusetts, August 14, 2026 Lantheus Holdings, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved...
Advertisement
